Literature DB >> 23876320

Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.

M Cristofanilli1, B Cymring, A Lu, H Rosenthal, S A Sadiq.   

Abstract

In the adult CNS, tissue-specific germinal niches, such as the subventricular zone of the lateral ventricles and the subgranular zone of the dentate gyrus of the hippocampus, contain multipotent neural precursor cells (NPCs) with the capacity to self-renew and differentiate into functional brain cells (i.e. neurons, astrocytes or oligodendrocytes). Due to their intrinsic plasticity, NPCs can be considered an essential part of the cellular mechanism(s) by which the CNS tries to repair itself after an injury. In inflammatory CNS disorders, such as multiple sclerosis (MS), neurogenesis and gliogenesis occur as part of an 'intrinsic' self-repair process. However, full and long-lasting repair in progressive MS is not achieved. Recent data suggest that endogenous NPCs, while trying to repair the damaged CNS in MS, may become the target of the disease itself. It is possible that factors produced during MS, like CNS-infiltrating blood-borne inflammatory mononuclear cells, reactive CNS-resident cells, and humoral mediators, can alter the physiological properties of NPCs, ultimately impairing their ability to promote neural regeneration. Here, we investigate the effect of cerebrospinal fluid (CSF) derived from primary progressive (PPMS) and secondary progressive (SPMS) MS patients (CSF-MS) on the survival, proliferation, and differentiation of commercially available human embryonic-derived NPCs named ENStem-A. We found that PPMS derived CSF markedly reduced the proliferation of ENStem-A and increased their differentiation toward neuronal and oligodendroglial cells, compared to control CSF. Similar but less striking results were seen when ENstem-A were treated with SPMS derived CSF. Our findings suggest that in both SPMS and PPMS the CNS milieu, as determined by extrapolation from CSF findings, may stimulate the endogenous pool of NPCs to differentiate into neurons and oligodendrocytes.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BDNF; CSF; D-PBS; Dulbecco’s phosphate-buffered saline; EAE; EDSS; FACS; GFAP; HRP; MBP; MRI; MS; NPCs; OPCs; PPMS; SPMS; SVZ; brain-derived neurotrophic factor; cerebrospinal fluid; expanded disability status scale; experimental allergic encephalomyelitis; fluorescence activated cell sorting; glial fibrillary acidic protein; horseradish peroxidase; in vitro model; magnetic resonance imaging; multiple sclerosis; myelin basic protein; neural precursor cells; neural progenitor cells; oligodendrocyte precursor cells; primary progressive multiple sclerosis; progressive; q-RT-PCR; quantitative real-time polymerase chain reaction; repair; secondary progressive multiple sclerosis; subventricular zone

Mesh:

Substances:

Year:  2013        PMID: 23876320     DOI: 10.1016/j.neuroscience.2013.07.022

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

1.  Human cerebrospinal fluid regulates proliferation and migration of stem cells through insulin-like growth factor-1.

Authors:  Mingxin Zhu; Yun Feng; Sean Dangelmajer; Hugo Guerrero-Cázares; Kaisorn L Chaichana; Christopher L Smith; Andre Levchenko; Ting Lei; Alfredo Quiñones-Hinojosa
Journal:  Stem Cells Dev       Date:  2015-01-15       Impact factor: 3.272

2.  Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.

Authors:  Jeffery D Haines; Oscar G Vidaurre; Fan Zhang; Ángela L Riffo-Campos; Josefa Castillo; Bonaventura Casanova; Patrizia Casaccia; Gerardo Lopez-Rodas
Journal:  Mult Scler       Date:  2015-05-06       Impact factor: 6.312

Review 3.  Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke.

Authors:  Kanako Itoh; Takakuni Maki; Josephine Lok; Ken Arai
Journal:  Brain Res       Date:  2015-05-08       Impact factor: 3.252

Review 4.  Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.

Authors:  Brett S Marro; Caroline A Blanc; Jeanne F Loring; Michael D Cahalan; Thomas E Lane
Journal:  Expert Rev Neurother       Date:  2014-10       Impact factor: 4.618

5.  Cellular responses to Sindbis virus infection of neural progenitors derived from human embryonic stem cells.

Authors:  Jie Xu; Rodney J Nash; Teryl K Frey
Journal:  BMC Res Notes       Date:  2014-10-24

Review 6.  Cerebrospinal fluid-stem cell interactions may pave the path for cell-based therapy in neurological diseases.

Authors:  Chao Ren; Peiyuan Yin; Neng Ren; Zhe Wang; Jiahui Wang; Caiyi Zhang; Wei Ge; Deqin Geng; Xiaotong Wang
Journal:  Stem Cell Res Ther       Date:  2018-03-09       Impact factor: 6.832

Review 7.  Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer's Disease.

Authors:  Ankit Tandon; Sangh Jyoti Singh; Rajnish Kumar Chaturvedi
Journal:  Biomed Res Int       Date:  2018-07-12       Impact factor: 3.411

8.  Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome.

Authors:  Letizia Mazzini; Maurizio Gelati; Daniela Celeste Profico; Gianni Sorarù; Daniela Ferrari; Massimiliano Copetti; Gianmarco Muzi; Claudia Ricciolini; Sandro Carletti; Cesare Giorgi; Cristina Spera; Domenico Frondizi; Stefano Masiero; Alessandro Stecco; Carlo Cisari; Enrica Bersano; Fabiola De Marchi; Maria Francesca Sarnelli; Giorgia Querin; Roberto Cantello; Francesco Petruzzelli; Annamaria Maglione; Cristina Zalfa; Elena Binda; Alberto Visioli; Domenico Trombetta; Barbara Torres; Laura Bernardini; Alessandra Gaiani; Maurilio Massara; Silvia Paolucci; Nicholas M Boulis; Angelo L Vescovi
Journal:  Stem Cells Transl Med       Date:  2019-05-18       Impact factor: 6.940

9.  Effect of Multiple Sclerosis Cerebrospinal Fluid and Oligodendroglia Cell Line Environment on Human Wharton's Jelly Mesenchymal Stem Cells Secretome.

Authors:  Karolina Salwierak-Głośna; Paweł Piątek; Małgorzata Domowicz; Mariola Świderek-Matysiak
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.